アレルギー性鼻炎治療薬のグローバル市場2024-2028:オフライン、オンライン

【英語タイトル】Global Allergy Rhinitis Drugs Market 2024-2028

Technavioが出版した調査資料(IRTNTR41321-24)・商品コード:IRTNTR41321-24
・発行会社(調査会社):Technavio
・発行日:2023年11月17日
・ページ数:約120
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後24時間以内)
・調査対象地域:グローバル
・産業分野:医薬品
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,500 ⇒換算¥370,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD4,000 ⇒換算¥592,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・送付(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
❖ レポートの概要 ❖

世界のアレルギー性鼻炎治療薬市場 2024年~2028年
アレルギー性鼻炎治療薬市場は、2023年から2028年にかけて31.7億米ドル成長し、予測期間中のCAGRは3.92%で加速すると予測されています。
この調査レポートは、アレルギー性鼻炎治療薬市場の全体的な分析、市場規模と予測、動向、成長促進要因、課題、約25のベンダーを網羅したベンダー分析などを掲載しています。
現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。アレルギー性鼻炎の有病率の増加、アンメットメディカルニーズの高さ、アレルギー性鼻炎診断の技術進歩などがアレルギー性鼻炎治療薬市場を牽引しています。

Technavio社のアレルギー性鼻炎治療薬市場は以下のように区分されます:

流通チャネル別
- オフライン
- オンライン

製品別
- 抗ヒスタミン薬
- 経鼻コルチコステロイド
- 免疫療法薬
- その他

地域別
- 北米
- ヨーロッパ
- アジア
- その他の地域(ROW)

本調査では、今後数年間のアレルギー性鼻炎治療薬市場の成長を牽引する主な要因の1つとして、新しい治療法の研究開発の増加を挙げています。また、市販薬の需要の増加や共同研究の増加も、アレルギー性鼻炎治療薬市場の大きな需要につながるでしょう。

当レポートでは、アレルギー性鼻炎治療薬市場について以下の分野をカバーしています:
- アレルギー性鼻炎治療薬市場の規模
- アレルギー性鼻炎治療薬市場の予測
- アレルギー性鼻炎治療薬市場の産業分析

本レポートでは、アレルギー性鼻炎治療薬市場の主要ベンダーであるALK Abello AS, Apotex Inc., Bayer AG, Cadila Pharmaceuticals Ltd., Catalent Inc., Dr Reddys Laboratories Ltd., Faes Farma SA, GlaxoSmithKline Plc, Glenmark Pharmaceuticals Ltd., HAL Allergy BV, Haleon Plc, Hikma Pharmaceuticals Plc, KYORIN Holdings Inc., Merck and Co. Inc., Mitsubishi Chemical Group Corp., Novartis AG, Sanofi SA, Stallergenes Greer Ltd., Ube Corp., and Viatris Inc.の詳細な分析を掲載しています。また、アレルギー性鼻炎治療薬市場の分析レポートには、市場成長に影響を与える今後の動向や課題に関する情報も含まれています。これは、企業が戦略を練り、来るべき成長機会をすべて活用するのに役立つものです。

本調査は、業界の主要参加者からのインプットを含め、一次情報と二次情報を客観的に組み合わせて実施しました。当レポートでは、主要ベンダーの分析に加え、包括的な市場とベンダーの状況を掲載しています。

Technavio社は、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数の情報源からのデータを調査、統合、総括する方法で、アレルギー性鼻炎治療薬市場の詳細な姿を提示しています。また、主要な業界インフルエンサーを特定することで、アレルギー性鼻炎治療薬市場の様々な側面を提示しています。提示されるデータは包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。市場調査報告書は、正確なアレルギー性鼻炎治療薬市場の成長を予測するために、完全な競争環境と、質的・量的調査を用いた綿密なベンダー選定方法と分析を提供します。

1. エグゼクティブサマリー
2. 市場状況
3. 市場規模
4. 歴史的市場規模
5. ファイブフォース分析
6. 世界のアレルギー性鼻炎治療薬市場規模:流通チャネル別
7. 世界のアレルギー性鼻炎治療薬市場規模:製品別
8. 顧客状況
9. 地域別状況
10. 成長要因・課題・動向
11. 企業状況
12. 企業分析
13. 付録

❖ レポートの目次 ❖

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary – Chart on Market Overview
o Exhibit 02: Executive Summary – Data Table on Market Overview
o Exhibit 03: Executive Summary – Chart on Global Market Characteristics
o Exhibit 04: Executive Summary – Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary – Chart on Market Segmentation by Distribution Channel
o Exhibit 06: Executive Summary – Chart on Market Segmentation by Product
o Exhibit 07: Executive Summary – Chart on Incremental Growth
o Exhibit 08: Executive Summary – Data Table on Incremental Growth
o Exhibit 09: Executive Summary – Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2023
o 3.4 Market outlook: Forecast for 2023-2028
o Exhibit 14: Chart on Global – Market size and forecast 2023-2028 ($ billion)
o Exhibit 15: Data Table on Global – Market size and forecast 2023-2028 ($ billion)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
• 4 Historic Market Size
o 4.1 Global allergy rhinitis drugs market 2018 – 2022
o Exhibit 18: Historic Market Size – Data Table on global allergy rhinitis drugs market 2018 – 2022 ($ billion)
o 4.2 Distribution Channel Segment Analysis 2018 – 2022
o Exhibit 19: Historic Market Size – Distribution Channel Segment 2018 – 2022 ($ billion)
o 4.3 Product Segment Analysis 2018 – 2022
o Exhibit 20: Historic Market Size – Product Segment 2018 – 2022 ($ billion)
o 4.4 Geography Segment Analysis 2018 – 2022
o Exhibit 21: Historic Market Size – Geography Segment 2018 – 2022 ($ billion)
o 4.5 Country Segment Analysis 2018 – 2022
o Exhibit 22: Historic Market Size – Country Segment 2018 – 2022 ($ billion)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis – Comparison between 2023 and 2028
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2023 and 2028
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2023 and 2028
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants – Impact of key factors in 2023 and 2028
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes – Impact of key factors in 2023 and 2028
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry – Impact of key factors in 2023 and 2028
o 5.7 Market condition
o Exhibit 29: Chart on Market condition – Five forces 2023 and 2028
• 6 Market Segmentation by Distribution Channel
o 6.1 Market segments
o Exhibit 30: Chart on Distribution Channel – Market share 2023-2028 (%)
o Exhibit 31: Data Table on Distribution Channel – Market share 2023-2028 (%)
o 6.2 Comparison by Distribution Channel
o Exhibit 32: Chart on Comparison by Distribution Channel
o Exhibit 33: Data Table on Comparison by Distribution Channel
o 6.3 Offline – Market size and forecast 2023-2028
o Exhibit 34: Chart on Offline – Market size and forecast 2023-2028 ($ billion)
o Exhibit 35: Data Table on Offline – Market size and forecast 2023-2028 ($ billion)
o Exhibit 36: Chart on Offline – Year-over-year growth 2023-2028 (%)
o Exhibit 37: Data Table on Offline – Year-over-year growth 2023-2028 (%)
o 6.4 Online – Market size and forecast 2023-2028
o Exhibit 38: Chart on Online – Market size and forecast 2023-2028 ($ billion)
o Exhibit 39: Data Table on Online – Market size and forecast 2023-2028 ($ billion)
o Exhibit 40: Chart on Online – Year-over-year growth 2023-2028 (%)
o Exhibit 41: Data Table on Online – Year-over-year growth 2023-2028 (%)
o 6.5 Market opportunity by Distribution Channel
o Exhibit 42: Market opportunity by Distribution Channel ($ billion)
o Exhibit 43: Data Table on Market opportunity by Distribution Channel ($ billion)
• 7 Market Segmentation by Product
o 7.1 Market segments
o Exhibit 44: Chart on Product – Market share 2023-2028 (%)
o Exhibit 45: Data Table on Product – Market share 2023-2028 (%)
o 7.2 Comparison by Product
o Exhibit 46: Chart on Comparison by Product
o Exhibit 47: Data Table on Comparison by Product
o 7.3 Antihistamines – Market size and forecast 2023-2028
o Exhibit 48: Chart on Antihistamines – Market size and forecast 2023-2028 ($ billion)
o Exhibit 49: Data Table on Antihistamines – Market size and forecast 2023-2028 ($ billion)
o Exhibit 50: Chart on Antihistamines – Year-over-year growth 2023-2028 (%)
o Exhibit 51: Data Table on Antihistamines – Year-over-year growth 2023-2028 (%)
o 7.4 Intranasal corticosteroids – Market size and forecast 2023-2028
o Exhibit 52: Chart on Intranasal corticosteroids – Market size and forecast 2023-2028 ($ billion)
o Exhibit 53: Data Table on Intranasal corticosteroids – Market size and forecast 2023-2028 ($ billion)
o Exhibit 54: Chart on Intranasal corticosteroids – Year-over-year growth 2023-2028 (%)
o Exhibit 55: Data Table on Intranasal corticosteroids – Year-over-year growth 2023-2028 (%)
o 7.5 Immunotherapies – Market size and forecast 2023-2028
o Exhibit 56: Chart on Immunotherapies – Market size and forecast 2023-2028 ($ billion)
o Exhibit 57: Data Table on Immunotherapies – Market size and forecast 2023-2028 ($ billion)
o Exhibit 58: Chart on Immunotherapies – Year-over-year growth 2023-2028 (%)
o Exhibit 59: Data Table on Immunotherapies – Year-over-year growth 2023-2028 (%)
o 7.6 Others – Market size and forecast 2023-2028
o Exhibit 60: Chart on Others – Market size and forecast 2023-2028 ($ billion)
o Exhibit 61: Data Table on Others – Market size and forecast 2023-2028 ($ billion)
o Exhibit 62: Chart on Others – Year-over-year growth 2023-2028 (%)
o Exhibit 63: Data Table on Others – Year-over-year growth 2023-2028 (%)
o 7.7 Market opportunity by Product
o Exhibit 64: Market opportunity by Product ($ billion)
o Exhibit 65: Data Table on Market opportunity by Product ($ billion)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 67: Chart on Market share By Geographical Landscape 2023-2028 (%)
o Exhibit 68: Data Table on Market share By Geographical Landscape 2023-2028 (%)
o 9.2 Geographic comparison
o Exhibit 69: Chart on Geographic comparison
o Exhibit 70: Data Table on Geographic comparison
o 9.3 North America – Market size and forecast 2023-2028
o Exhibit 71: Chart on North America – Market size and forecast 2023-2028 ($ billion)
o Exhibit 72: Data Table on North America – Market size and forecast 2023-2028 ($ billion)
o Exhibit 73: Chart on North America – Year-over-year growth 2023-2028 (%)
o Exhibit 74: Data Table on North America – Year-over-year growth 2023-2028 (%)
o 9.4 Europe – Market size and forecast 2023-2028
o Exhibit 75: Chart on Europe – Market size and forecast 2023-2028 ($ billion)
o Exhibit 76: Data Table on Europe – Market size and forecast 2023-2028 ($ billion)
o Exhibit 77: Chart on Europe – Year-over-year growth 2023-2028 (%)
o Exhibit 78: Data Table on Europe – Year-over-year growth 2023-2028 (%)
o 9.5 Asia – Market size and forecast 2023-2028
o Exhibit 79: Chart on Asia – Market size and forecast 2023-2028 ($ billion)
o Exhibit 80: Data Table on Asia – Market size and forecast 2023-2028 ($ billion)
o Exhibit 81: Chart on Asia – Year-over-year growth 2023-2028 (%)
o Exhibit 82: Data Table on Asia – Year-over-year growth 2023-2028 (%)
o 9.6 Rest of World (ROW) – Market size and forecast 2023-2028
o Exhibit 83: Chart on Rest of World (ROW) – Market size and forecast 2023-2028 ($ billion)
o Exhibit 84: Data Table on Rest of World (ROW) – Market size and forecast 2023-2028 ($ billion)
o Exhibit 85: Chart on Rest of World (ROW) – Year-over-year growth 2023-2028 (%)
o Exhibit 86: Data Table on Rest of World (ROW) – Year-over-year growth 2023-2028 (%)
o 9.7 US – Market size and forecast 2023-2028
o Exhibit 87: Chart on US – Market size and forecast 2023-2028 ($ billion)
o Exhibit 88: Data Table on US – Market size and forecast 2023-2028 ($ billion)
o Exhibit 89: Chart on US – Year-over-year growth 2023-2028 (%)
o Exhibit 90: Data Table on US – Year-over-year growth 2023-2028 (%)
o 9.8 Germany – Market size and forecast 2023-2028
o Exhibit 91: Chart on Germany – Market size and forecast 2023-2028 ($ billion)
o Exhibit 92: Data Table on Germany – Market size and forecast 2023-2028 ($ billion)
o Exhibit 93: Chart on Germany – Year-over-year growth 2023-2028 (%)
o Exhibit 94: Data Table on Germany – Year-over-year growth 2023-2028 (%)
o 9.9 UK – Market size and forecast 2023-2028
o Exhibit 95: Chart on UK – Market size and forecast 2023-2028 ($ billion)
o Exhibit 96: Data Table on UK – Market size and forecast 2023-2028 ($ billion)
o Exhibit 97: Chart on UK – Year-over-year growth 2023-2028 (%)
o Exhibit 98: Data Table on UK – Year-over-year growth 2023-2028 (%)
o 9.10 Japan – Market size and forecast 2023-2028
o Exhibit 99: Chart on Japan – Market size and forecast 2023-2028 ($ billion)
o Exhibit 100: Data Table on Japan – Market size and forecast 2023-2028 ($ billion)
o Exhibit 101: Chart on Japan – Year-over-year growth 2023-2028 (%)
o Exhibit 102: Data Table on Japan – Year-over-year growth 2023-2028 (%)
o 9.11 France – Market size and forecast 2023-2028
o Exhibit 103: Chart on France – Market size and forecast 2023-2028 ($ billion)
o Exhibit 104: Data Table on France – Market size and forecast 2023-2028 ($ billion)
o Exhibit 105: Chart on France – Year-over-year growth 2023-2028 (%)
o Exhibit 106: Data Table on France – Year-over-year growth 2023-2028 (%)
o 9.12 Market opportunity By Geographical Landscape
o Exhibit 107: Market opportunity By Geographical Landscape ($ billion)
o Exhibit 108: Data Tables on Market opportunity By Geographical Landscape ($ billion)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 109: Impact of drivers and challenges in 2023 and 2028
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 110: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 111: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 112: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 113: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 114: Matrix on vendor position and classification
o 12.3 ALK Abello AS
o Exhibit 115: ALK Abello AS – Overview
o Exhibit 116: ALK Abello AS – Product / Service
o Exhibit 117: ALK Abello AS – Key offerings
o 12.4 Apotex Inc.
o Exhibit 118: Apotex Inc. – Overview
o Exhibit 119: Apotex Inc. – Product / Service
o Exhibit 120: Apotex Inc. – Key offerings
o 12.5 Bayer AG
o Exhibit 121: Bayer AG – Overview
o Exhibit 122: Bayer AG – Business segments
o Exhibit 123: Bayer AG – Key news
o Exhibit 124: Bayer AG – Key offerings
o Exhibit 125: Bayer AG – Segment focus
o 12.6 Dr Reddys Laboratories Ltd.
o Exhibit 126: Dr Reddys Laboratories Ltd. – Overview
o Exhibit 127: Dr Reddys Laboratories Ltd. – Business segments
o Exhibit 128: Dr Reddys Laboratories Ltd. – Key offerings
o Exhibit 129: Dr Reddys Laboratories Ltd. – Segment focus
o 12.7 Faes Farma SA
o Exhibit 130: Faes Farma SA – Overview
o Exhibit 131: Faes Farma SA – Product / Service
o Exhibit 132: Faes Farma SA – Key offerings
o 12.8 GlaxoSmithKline Plc
o Exhibit 133: GlaxoSmithKline Plc – Overview
o Exhibit 134: GlaxoSmithKline Plc – Business segments
o Exhibit 135: GlaxoSmithKline Plc – Key news
o Exhibit 136: GlaxoSmithKline Plc – Key offerings
o Exhibit 137: GlaxoSmithKline Plc – Segment focus
o 12.9 Glenmark Pharmaceuticals Ltd.
o Exhibit 138: Glenmark Pharmaceuticals Ltd. – Overview
o Exhibit 139: Glenmark Pharmaceuticals Ltd. – Product / Service
o Exhibit 140: Glenmark Pharmaceuticals Ltd. – Key offerings
o 12.10 Haleon Plc
o Exhibit 141: Haleon Plc – Overview
o Exhibit 142: Haleon Plc – Business segments
o Exhibit 143: Haleon Plc – Key offerings
o Exhibit 144: Haleon Plc – Segment focus
o 12.11 Hikma Pharmaceuticals Plc
o Exhibit 145: Hikma Pharmaceuticals Plc – Overview
o Exhibit 146: Hikma Pharmaceuticals Plc – Business segments
o Exhibit 147: Hikma Pharmaceuticals Plc – Key offerings
o Exhibit 148: Hikma Pharmaceuticals Plc – Segment focus
o 12.12 Merck and Co. Inc.
o Exhibit 149: Merck and Co. Inc. – Overview
o Exhibit 150: Merck and Co. Inc. – Business segments
o Exhibit 151: Merck and Co. Inc. – Key news
o Exhibit 152: Merck and Co. Inc. – Key offerings
o Exhibit 153: Merck and Co. Inc. – Segment focus
o 12.13 Mitsubishi Chemical Group Corp.
o Exhibit 154: Mitsubishi Chemical Group Corp. – Overview
o Exhibit 155: Mitsubishi Chemical Group Corp. – Business segments
o Exhibit 156: Mitsubishi Chemical Group Corp. – Key offerings
o Exhibit 157: Mitsubishi Chemical Group Corp. – Segment focus
o 12.14 Novartis AG
o Exhibit 158: Novartis AG – Overview
o Exhibit 159: Novartis AG – Business segments
o Exhibit 160: Novartis AG – Key offerings
o Exhibit 161: Novartis AG – Segment focus
o 12.15 Sanofi SA
o Exhibit 162: Sanofi SA – Overview
o Exhibit 163: Sanofi SA – Business segments
o Exhibit 164: Sanofi SA – Key news
o Exhibit 165: Sanofi SA – Key offerings
o Exhibit 166: Sanofi SA – Segment focus
o 12.16 Stallergenes Greer Ltd.
o Exhibit 167: Stallergenes Greer Ltd. – Overview
o Exhibit 168: Stallergenes Greer Ltd. – Product / Service
o Exhibit 169: Stallergenes Greer Ltd. – Key offerings
o 12.17 Viatris Inc.
o Exhibit 170: Viatris Inc. – Overview
o Exhibit 171: Viatris Inc. – Business segments
o Exhibit 172: Viatris Inc. – Key news
o Exhibit 173: Viatris Inc. – Key offerings
o Exhibit 174: Viatris Inc. – Segment focus
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 175: Inclusions checklist
o Exhibit 176: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 177: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 178: Research methodology
o Exhibit 179: Validation techniques employed for market sizing
o Exhibit 180: Information sources
o 13.5 List of abbreviations
o Exhibit 181: List of abbreviations

Exhibits:
Exhibits1: Executive Summary – Chart on Market Overview
Exhibits2: Executive Summary – Data Table on Market Overview
Exhibits3: Executive Summary – Chart on Global Market Characteristics
Exhibits4: Executive Summary – Chart on Market By Geographical Landscape
Exhibits5: Executive Summary – Chart on Market Segmentation by Distribution Channel
Exhibits6: Executive Summary – Chart on Market Segmentation by Product
Exhibits7: Executive Summary – Chart on Incremental Growth
Exhibits8: Executive Summary – Data Table on Incremental Growth
Exhibits9: Executive Summary – Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global – Market size and forecast 2023-2028 ($ billion)
Exhibits15: Data Table on Global – Market size and forecast 2023-2028 ($ billion)
Exhibits16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits18: Historic Market Size – Data Table on global allergy rhinitis drugs market 2018 – 2022 ($ billion)
Exhibits19: Historic Market Size – Distribution Channel Segment 2018 – 2022 ($ billion)
Exhibits20: Historic Market Size – Product Segment 2018 – 2022 ($ billion)
Exhibits21: Historic Market Size – Geography Segment 2018 – 2022 ($ billion)
Exhibits22: Historic Market Size – Country Segment 2018 – 2022 ($ billion)
Exhibits23: Five forces analysis – Comparison between 2023 and 2028
Exhibits24: Chart on Bargaining power of buyers – Impact of key factors 2023 and 2028
Exhibits25: Bargaining power of suppliers – Impact of key factors in 2023 and 2028
Exhibits26: Threat of new entrants – Impact of key factors in 2023 and 2028
Exhibits27: Threat of substitutes – Impact of key factors in 2023 and 2028
Exhibits28: Threat of rivalry – Impact of key factors in 2023 and 2028
Exhibits29: Chart on Market condition – Five forces 2023 and 2028
Exhibits30: Chart on Distribution Channel – Market share 2023-2028 (%)
Exhibits31: Data Table on Distribution Channel – Market share 2023-2028 (%)
Exhibits32: Chart on Comparison by Distribution Channel
Exhibits33: Data Table on Comparison by Distribution Channel
Exhibits34: Chart on Offline – Market size and forecast 2023-2028 ($ billion)
Exhibits35: Data Table on Offline – Market size and forecast 2023-2028 ($ billion)
Exhibits36: Chart on Offline – Year-over-year growth 2023-2028 (%)
Exhibits37: Data Table on Offline – Year-over-year growth 2023-2028 (%)
Exhibits38: Chart on Online – Market size and forecast 2023-2028 ($ billion)
Exhibits39: Data Table on Online – Market size and forecast 2023-2028 ($ billion)
Exhibits40: Chart on Online – Year-over-year growth 2023-2028 (%)
Exhibits41: Data Table on Online – Year-over-year growth 2023-2028 (%)
Exhibits42: Market opportunity by Distribution Channel ($ billion)
Exhibits43: Data Table on Market opportunity by Distribution Channel ($ billion)
Exhibits44: Chart on Product – Market share 2023-2028 (%)
Exhibits45: Data Table on Product – Market share 2023-2028 (%)
Exhibits46: Chart on Comparison by Product
Exhibits47: Data Table on Comparison by Product
Exhibits48: Chart on Antihistamines – Market size and forecast 2023-2028 ($ billion)
Exhibits49: Data Table on Antihistamines – Market size and forecast 2023-2028 ($ billion)
Exhibits50: Chart on Antihistamines – Year-over-year growth 2023-2028 (%)
Exhibits51: Data Table on Antihistamines – Year-over-year growth 2023-2028 (%)
Exhibits52: Chart on Intranasal corticosteroids – Market size and forecast 2023-2028 ($ billion)
Exhibits53: Data Table on Intranasal corticosteroids – Market size and forecast 2023-2028 ($ billion)
Exhibits54: Chart on Intranasal corticosteroids – Year-over-year growth 2023-2028 (%)
Exhibits55: Data Table on Intranasal corticosteroids – Year-over-year growth 2023-2028 (%)
Exhibits56: Chart on Immunotherapies – Market size and forecast 2023-2028 ($ billion)
Exhibits57: Data Table on Immunotherapies – Market size and forecast 2023-2028 ($ billion)
Exhibits58: Chart on Immunotherapies – Year-over-year growth 2023-2028 (%)
Exhibits59: Data Table on Immunotherapies – Year-over-year growth 2023-2028 (%)
Exhibits60: Chart on Others – Market size and forecast 2023-2028 ($ billion)
Exhibits61: Data Table on Others – Market size and forecast 2023-2028 ($ billion)
Exhibits62: Chart on Others – Year-over-year growth 2023-2028 (%)
Exhibits63: Data Table on Others – Year-over-year growth 2023-2028 (%)
Exhibits64: Market opportunity by Product ($ billion)
Exhibits65: Data Table on Market opportunity by Product ($ billion)
Exhibits66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits67: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits68: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits69: Chart on Geographic comparison
Exhibits70: Data Table on Geographic comparison
Exhibits71: Chart on North America – Market size and forecast 2023-2028 ($ billion)
Exhibits72: Data Table on North America – Market size and forecast 2023-2028 ($ billion)
Exhibits73: Chart on North America – Year-over-year growth 2023-2028 (%)
Exhibits74: Data Table on North America – Year-over-year growth 2023-2028 (%)
Exhibits75: Chart on Europe – Market size and forecast 2023-2028 ($ billion)
Exhibits76: Data Table on Europe – Market size and forecast 2023-2028 ($ billion)
Exhibits77: Chart on Europe – Year-over-year growth 2023-2028 (%)
Exhibits78: Data Table on Europe – Year-over-year growth 2023-2028 (%)
Exhibits79: Chart on Asia – Market size and forecast 2023-2028 ($ billion)
Exhibits80: Data Table on Asia – Market size and forecast 2023-2028 ($ billion)
Exhibits81: Chart on Asia – Year-over-year growth 2023-2028 (%)
Exhibits82: Data Table on Asia – Year-over-year growth 2023-2028 (%)
Exhibits83: Chart on Rest of World (ROW) – Market size and forecast 2023-2028 ($ billion)
Exhibits84: Data Table on Rest of World (ROW) – Market size and forecast 2023-2028 ($ billion)
Exhibits85: Chart on Rest of World (ROW) – Year-over-year growth 2023-2028 (%)
Exhibits86: Data Table on Rest of World (ROW) – Year-over-year growth 2023-2028 (%)
Exhibits87: Chart on US – Market size and forecast 2023-2028 ($ billion)
Exhibits88: Data Table on US – Market size and forecast 2023-2028 ($ billion)
Exhibits89: Chart on US – Year-over-year growth 2023-2028 (%)
Exhibits90: Data Table on US – Year-over-year growth 2023-2028 (%)
Exhibits91: Chart on Germany – Market size and forecast 2023-2028 ($ billion)
Exhibits92: Data Table on Germany – Market size and forecast 2023-2028 ($ billion)
Exhibits93: Chart on Germany – Year-over-year growth 2023-2028 (%)
Exhibits94: Data Table on Germany – Year-over-year growth 2023-2028 (%)
Exhibits95: Chart on UK – Market size and forecast 2023-2028 ($ billion)
Exhibits96: Data Table on UK – Market size and forecast 2023-2028 ($ billion)
Exhibits97: Chart on UK – Year-over-year growth 2023-2028 (%)
Exhibits98: Data Table on UK – Year-over-year growth 2023-2028 (%)
Exhibits99: Chart on Japan – Market size and forecast 2023-2028 ($ billion)
Exhibits100: Data Table on Japan – Market size and forecast 2023-2028 ($ billion)
Exhibits101: Chart on Japan – Year-over-year growth 2023-2028 (%)
Exhibits102: Data Table on Japan – Year-over-year growth 2023-2028 (%)
Exhibits103: Chart on France – Market size and forecast 2023-2028 ($ billion)
Exhibits104: Data Table on France – Market size and forecast 2023-2028 ($ billion)
Exhibits105: Chart on France – Year-over-year growth 2023-2028 (%)
Exhibits106: Data Table on France – Year-over-year growth 2023-2028 (%)
Exhibits107: Market opportunity By Geographical Landscape ($ billion)
Exhibits108: Data Tables on Market opportunity By Geographical Landscape ($ billion)
Exhibits109: Impact of drivers and challenges in 2023 and 2028
Exhibits110: Overview on Criticality of inputs and Factors of differentiation
Exhibits111: Overview on factors of disruption
Exhibits112: Impact of key risks on business
Exhibits113: Vendors covered
Exhibits114: Matrix on vendor position and classification
Exhibits115: ALK Abello AS – Overview
Exhibits116: ALK Abello AS – Product / Service
Exhibits117: ALK Abello AS – Key offerings
Exhibits118: Apotex Inc. – Overview
Exhibits119: Apotex Inc. – Product / Service
Exhibits120: Apotex Inc. – Key offerings
Exhibits121: Bayer AG – Overview
Exhibits122: Bayer AG – Business segments
Exhibits123: Bayer AG – Key news
Exhibits124: Bayer AG – Key offerings
Exhibits125: Bayer AG – Segment focus
Exhibits126: Dr Reddys Laboratories Ltd. – Overview
Exhibits127: Dr Reddys Laboratories Ltd. – Business segments
Exhibits128: Dr Reddys Laboratories Ltd. – Key offerings
Exhibits129: Dr Reddys Laboratories Ltd. – Segment focus
Exhibits130: Faes Farma SA – Overview
Exhibits131: Faes Farma SA – Product / Service
Exhibits132: Faes Farma SA – Key offerings
Exhibits133: GlaxoSmithKline Plc – Overview
Exhibits134: GlaxoSmithKline Plc – Business segments
Exhibits135: GlaxoSmithKline Plc – Key news
Exhibits136: GlaxoSmithKline Plc – Key offerings
Exhibits137: GlaxoSmithKline Plc – Segment focus
Exhibits138: Glenmark Pharmaceuticals Ltd. – Overview
Exhibits139: Glenmark Pharmaceuticals Ltd. – Product / Service
Exhibits140: Glenmark Pharmaceuticals Ltd. – Key offerings
Exhibits141: Haleon Plc – Overview
Exhibits142: Haleon Plc – Business segments
Exhibits143: Haleon Plc – Key offerings
Exhibits144: Haleon Plc – Segment focus
Exhibits145: Hikma Pharmaceuticals Plc – Overview
Exhibits146: Hikma Pharmaceuticals Plc – Business segments
Exhibits147: Hikma Pharmaceuticals Plc – Key offerings
Exhibits148: Hikma Pharmaceuticals Plc – Segment focus
Exhibits149: Merck and Co. Inc. – Overview
Exhibits150: Merck and Co. Inc. – Business segments
Exhibits151: Merck and Co. Inc. – Key news
Exhibits152: Merck and Co. Inc. – Key offerings
Exhibits153: Merck and Co. Inc. – Segment focus
Exhibits154: Mitsubishi Chemical Group Corp. – Overview
Exhibits155: Mitsubishi Chemical Group Corp. – Business segments
Exhibits156: Mitsubishi Chemical Group Corp. – Key offerings
Exhibits157: Mitsubishi Chemical Group Corp. – Segment focus
Exhibits158: Novartis AG – Overview
Exhibits159: Novartis AG – Business segments
Exhibits160: Novartis AG – Key offerings
Exhibits161: Novartis AG – Segment focus
Exhibits162: Sanofi SA – Overview
Exhibits163: Sanofi SA – Business segments
Exhibits164: Sanofi SA – Key news
Exhibits165: Sanofi SA – Key offerings
Exhibits166: Sanofi SA – Segment focus
Exhibits167: Stallergenes Greer Ltd. – Overview
Exhibits168: Stallergenes Greer Ltd. – Product / Service
Exhibits169: Stallergenes Greer Ltd. – Key offerings
Exhibits170: Viatris Inc. – Overview
Exhibits171: Viatris Inc. – Business segments
Exhibits172: Viatris Inc. – Key news
Exhibits173: Viatris Inc. – Key offerings
Exhibits174: Viatris Inc. – Segment focus
Exhibits175: Inclusions checklist
Exhibits176: Exclusions checklist
Exhibits177: Currency conversion rates for US$
Exhibits178: Research methodology
Exhibits179: Validation techniques employed for market sizing
Exhibits180: Information sources
Exhibits181: List of abbreviations



★調査レポート[アレルギー性鼻炎治療薬のグローバル市場2024-2028:オフライン、オンライン] (コード:IRTNTR41321-24)販売に関する免責事項を必ずご確認ください。
★調査レポート[アレルギー性鼻炎治療薬のグローバル市場2024-2028:オフライン、オンライン]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆